HKIC expands tech footprint, signs strategic cooperation with BioMap to develop HK as AI and biotech hub

Hong Kong Investment Corporation Limited (HKIC) has signed a strategic cooperation agreement with BioMap, which specializes in biotech artificial intelligence large models today (June 24).

This marks the second strategic partnership announced by HKIC within two weeks. The company will provide resources and support for BioMap's development in Hong Kong.

Financial Secretary Paul Chan attended the signing ceremony and delivered a speech emphasizing Hong Kong's solid foundation in artificial intelligence and life sciences.

Chan noted that accelerating development in these fields would help Hong Kong seize opportunities in related industries. Hong Kong boasts world-leading universities and research institutions, providing a solid foundation for biotechnology and computer science.

Under the "one country, two systems" principle, Hong Kong maintains the free flow of information and data. As an international financial center, it is confident that more tech companies will choose Hong Kong as their R&D base, stated Chan.

Clara Chan, CEO of HKIC, highlighted that the company's lead investment projects could attract at least double the market capital to the same project, with significant contributions from offshore institutional investors and corporations.

Liu Wei, co-founder and CEO of BioMap stated that the company is exploring various listing plans and will prioritize listing in Hong Kong.